Intramolecular Immunological Signal Hypothesis Revived - Structural Background of Signalling Revealed by Using Congo Red as a Specific Tool
暂无分享,去创建一个
P. Piwowar | L. Konieczny | P. Marszałek | I. Roterman | P. Marszalek | L. Konieczny | M. Król | J. Rybarska | A. Jagusiak | G. Zemanek | B. Piekarska | B. Stopa | P. Piwowar | A. Jagusiak | M. Król | B. Piekarska | I. Roterman | J. Rybarska | B. Stopa | G. Zemanek
[1] Irena Roterman-Konieczna,et al. Congo Red Bound to -1-Proteinase Inhibitor As a Model of Supramolecular Ligand and Protein Complex , 1998, Comput. Chem..
[2] H. Metzger. Fc receptors and the action of antibodies , 1990 .
[3] A. Edmundson,et al. Local and transmitted conformational changes on complexation of an anti-sweetener Fab. , 1994, Journal of molecular biology.
[4] Piet Gros,et al. Complement Is Activated by IgG Hexamers Assembled at the Cell Surface , 2014, Science.
[5] I. Roterman,et al. The use of congo red as a lyotropic liquid crystal to carry stains in a model immunotargeting system--microscopic studies. , 1997, Folia histochemica et cytobiologica.
[6] C. Chang,et al. Dual conformations of an immunoglobulin light-chain dimer: heterogeneity of antigen specificity and idiotope profile may result from multiple variable-domain interaction mechanisms. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[7] Masayuki Oda,et al. Evidence of allosteric conformational changes in the antibody constant region upon antigen binding. , 2003, International immunology.
[8] D. Fisher,et al. Iodination of thyroliberin by use of Iodogen. , 1984, Clinical chemistry.
[9] H. Lilie. Folding of the Fab fragment within the intact antibody , 1997, FEBS letters.
[10] Leszek Konieczny,et al. The structure and protein binding of amyloid-specific dye reagents. , 2003, Acta biochimica Polonica.
[11] I. Roterman,et al. Supramolecular ligands: monomer structure and protein ligation capability. , 1998, Biochimie.
[12] S. Morrison,et al. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[13] Christine Gaboriaud,et al. The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties* , 2003, Journal of Biological Chemistry.
[14] Andreas Plückthun,et al. Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. , 2004, Methods.
[15] Leszek Konieczny,et al. The Increased Flexibility of CDR Loops Generated in Antibodies by Congo Red Complexation Favors Antigen Binding , 2006, Journal of biomolecular structure & dynamics.
[16] D. Röthlisberger,et al. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. , 2005, Journal of molecular biology.
[17] G. Schmer,et al. The synthesis of a water soluble complement activating polyacrylic acid-IgG polymer. , 1994, Journal of biomaterials science. Polymer edition.
[18] B. Gorick,et al. Antibody density on rat red cells determines the rate of activation of the complement component Cl , 1985, European journal of immunology.
[19] E. Voss,et al. Polyclonal antibodies specific for liganded active site (metatype) of a high affinity anti-hapten monoclonal antibody. , 1988, Molecular immunology.
[20] Alexander D. MacKerell,et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.
[21] L. J. Harris,et al. Comparison of intact antibody structures and the implications for effector function. , 1999, Advances in immunology.
[22] S. Morrison,et al. Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions. , 2004, Molecular immunology.
[23] V. Schumaker,et al. Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement. , 1976, Biochemistry.
[24] I Roterman,et al. The effect of azo dyes on the formation of immune complexes. , 1991, Archivum immunologiae et therapiae experimentalis.
[25] T. N. Bhat,et al. Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding , 1990, Nature.
[26] F. Claas,et al. Human Leukocyte Antigen Antibodies and Human Complement Activation: Role of IgG Subclass, Specificity, and Cytotoxic Potential , 2004, Transplantation.
[27] L Konieczny,et al. Bis-azo dyes interference with effector activation of antibodies. , 1993, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[28] Mayuko Takeda-Shitaka,et al. Interaction between the antigen and antibody is controlled by the constant domains: Normal mode dynamics of the HEL–HyHEL‐10 complex , 2003, Protein science : a publication of the Protein Society.
[29] I. Roterman,et al. Analysis of correlated domain motions in IgG light chain reveals possible mechanisms of immunological signal transduction , 2005, Proteins.
[30] I Roterman,et al. Bis azo dyes--studies on the mechanism of complex formation with IgG modulated by heating or antigen binding. , 1993, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[31] R. Webster,et al. Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. , 1992, Journal of molecular biology.
[32] P. M. Buck,et al. Impact of deglycosylation and thermal stress on conformational stability of a full length murine igG2a monoclonal antibody: Observations from molecular dynamics simulations , 2013, Proteins.
[33] A. Plückthun,et al. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding. , 2001, Journal of molecular biology.
[34] J. Xu,et al. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. , 2000, Immunity.
[35] T. Tomasi,et al. Effector Sites on Antibodies , 1979 .
[36] B. Dzantiev,et al. Polyvalent interaction of antibodies with bacterial cells. , 1990, Molecular immunology.
[37] T. So,et al. Favourable interaction between heavy and light chains arrests the undesirable oligomerization of heavy chains in the refolding of denatured and reduced immunoglobulin G , 1997, Cellular and Molecular Life Sciences CMLS.
[38] J. Tanner,et al. Crystal structure of an antigen-binding fragment bound to single-stranded DNA. , 2001, Journal of molecular biology.
[39] S. V. Anisimov,et al. Congo red and protein aggregation in neurodegenerative diseases , 2007, Brain Research Reviews.
[40] J. Schlessinger,et al. Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size. , 1975, Biochemistry.
[41] K. Chou,et al. A Model for Structure-Dependent Binding of Congo Red to Alzheimer β-Amyloid Fibrils , 1998, Neurobiology of Aging.
[42] E. Hewat,et al. Bivalent binding of a neutralising antibody to a calicivirus involves the torsional flexibility of the antibody hinge. , 1997, Journal of molecular biology.
[43] I. Roterman,et al. Local and long‐range structural effects caused by the removal of the N‐terminal polypeptide fragment from immunoglobulin L chain λ , 2003, Biopolymers.
[44] I Roterman,et al. Heat‐induced formation of a specific binding site for self‐assembled congo red in the V domain of immunoglobulin L chain λ , 2001, Biopolymers.
[45] I. Wilson,et al. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes. , 1993, Journal of molecular biology.
[46] Y. Duan,et al. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. , 2007, Journal of the American Chemical Society.
[47] M. Oda,et al. Conformational changes in the antibody constant domains upon hapten-binding. , 2005, Molecular immunology.
[48] T. Baker,et al. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] E. F. Ullman,et al. Anti-immune complex antibodies enhance affinity and specificity of primary antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. B. Gleason,et al. The X-ray Crystal Structure of the Sulfonated Azo Dye Congo Red, a Non-Peptidic Inhibitor of HIV-1 Protease which also Binds to Reverse Transcriptase and Amyloid Proteins , 1995 .
[51] V. Uversky,et al. Is Congo Red an Amyloid-specific Dye?* , 2001, The Journal of Biological Chemistry.
[52] Enrique Vargas‐Madrazo,et al. An improved model of association for VH–VL immunoglobulin domains: Asymmetries between VH and VL in the packing of some interface residues , 2003, Journal of molecular recognition : JMR.
[53] P. Ramsland,et al. Crystal structures of human antibodies: a detailed and unfinished tapestry of immunoglobulin gene products , 2002, Journal of molecular recognition : JMR.
[54] Leszek Konieczny,et al. Self‐assembly of Congo Red—A theoretical and experimental approach to identify its supramolecular organization in water and salt solutions , 1998 .
[55] W G Laver,et al. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. , 1992, Journal of molecular biology.
[56] I. Roterman,et al. Supramolecularity creates nonstandard protein ligands. , 1999, Acta biochimica Polonica.
[57] M. Manning,et al. Congo Red Populates Partially Unfolded States of an Amyloidogenic Protein to Enhance Aggregation and Amyloid Fibril Formation* , 2003, The Journal of Biological Chemistry.
[58] M. Sela,et al. Shape and volume of fragments Fab' and (Fab')2 of anti-poly(D-alanyl) antibodies in the presence and absence of tetra-D-alanine as determined by small-angle x-ray scattering. , 1975, Biochemistry.
[59] R L Stanfield,et al. Antibody-antigen interactions: new structures and new conformational changes. , 1994, Current opinion in structural biology.
[60] Mats Ohlin,et al. Length of the antibody heavy chain complementarity determining region 3 as a specificity‐determining factor , 2004, Journal of molecular recognition : JMR.